- Filed
- Jul 15, 2025 12:00 AM ET
- Period of report
- —
Amendment.
Amends a previously filed report.
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2024 · Jul 11, 2025 | 107.85M sh |
| Shares Diluted | Q1 2024 · Mar 31, 2024 | 107.85M sh |
| Shares Diluted restated | Q1 2024 · Mar 31, 2023 | 107.84M sh |
| Operating Cash Flow restated | Q1 2024 · Mar 31, 2024 | −$67.62K |
| Operating Cash Flow restated | Q1 2024 · Mar 31, 2023 | −$44.12K |
| Long Term Debt restated | Q1 2024 · Mar 31, 2024 | $1.2M |
| Short Term Debt restated | Q1 2024 · Mar 31, 2024 | $17.62K |
| Short Term Debt | Q1 2024 · Dec 31, 2023 | $79.44K |
| Cash And Equivalents | Q1 2024 · Mar 31, 2024 | $133.79K |
| Stockholders Equity restated | Q1 2024 · Mar 31, 2024 | −$1.02M |
| Stockholders Equity | Q1 2024 · Dec 31, 2023 | −$962.13K |
| Stockholders Equity | Q1 2024 · Mar 31, 2023 | −$749.47K |
| Stockholders Equity | Q1 2024 · Dec 31, 2022 | $104.5K |
| Current Liabilities restated | Q1 2024 · Mar 31, 2024 | $159.23K |
| Current Liabilities | Q1 2024 · Dec 31, 2023 | $338.49K |
| Total Liabilities restated | Q1 2024 · Mar 31, 2024 | $1.34M |
| Total Liabilities | Q1 2024 · Dec 31, 2023 | $1.18M |
| Current Assets restated | Q1 2024 · Mar 31, 2024 | $138.89K |
| Current Assets | Q1 2024 · Dec 31, 2023 | $27.17K |
| Total Assets restated | Q1 2024 · Mar 31, 2024 | $321.56K |
| Total Assets | Q1 2024 · Dec 31, 2023 | $216.55K |
| Eps Diluted | Q1 2024 · Mar 31, 2024 | $0.00 |
| Eps Diluted restated | Q1 2024 · Mar 31, 2023 | −$0.01 |
| Eps Basic | Q1 2024 · Mar 31, 2024 | $0.00 |
| Eps Basic restated | Q1 2024 · Mar 31, 2023 | −$0.01 |
| Sga Expense restated | Q1 2024 · Mar 31, 2024 | $105.97K |
| Sga Expense restated | Q1 2024 · Mar 31, 2023 | $106.33K |
| Net Income restated | Q1 2024 · Mar 31, 2024 | −$123.71K |
| Net Income | Q1 2024 · Mar 31, 2023 | −$928.4K |
| Operating Income restated | Q1 2024 · Mar 31, 2024 | −$106.52K |
| Operating Income restated | Q1 2024 · Mar 31, 2023 | −$146.75K |
| Gross Profit | Q1 2024 · Mar 31, 2024 | $7.38K |
| Gross Profit | Q1 2024 · Mar 31, 2023 | $1.89K |
| Cost Of Revenue | Q1 2024 · Mar 31, 2024 | $4.62K |
| Cost Of Revenue | Q1 2024 · Mar 31, 2023 | $6.11K |
| Revenue | Q1 2024 · Mar 31, 2024 | $12K |
| Revenue | Q1 2024 · Mar 31, 2023 | $8K |